Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH‐induced dogs with an anti‐proliferative agent called tadalafil

Background Finding a medical treatment which can combat cell proliferation and relax smooth muscles in canine benign prostatic hyperplasia (BPH) appears to be imperative. Aims This study aimed to evaluate the oxidative stress and inflammatory proteins following the treatment of dogs induced for BPH...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of veterinary pharmacology and therapeutics 2019-11, Vol.42 (6), p.665-672
Hauptverfasser: Dearakhshandeh, Nooshin, Mogheiseh, Asghar, Nazifi, Saeed, Ahrari Khafi, Mohammad Saeed, Abbaszadeh Hasiri, Mohammad, Golchin‐Rad, Kamran
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 672
container_issue 6
container_start_page 665
container_title Journal of veterinary pharmacology and therapeutics
container_volume 42
creator Dearakhshandeh, Nooshin
Mogheiseh, Asghar
Nazifi, Saeed
Ahrari Khafi, Mohammad Saeed
Abbaszadeh Hasiri, Mohammad
Golchin‐Rad, Kamran
description Background Finding a medical treatment which can combat cell proliferation and relax smooth muscles in canine benign prostatic hyperplasia (BPH) appears to be imperative. Aims This study aimed to evaluate the oxidative stress and inflammatory proteins following the treatment of dogs induced for BPH with an anti‐proliferative agent called tadalafil. Materials and Methods Twenty‐five adult intact male dogs were randomly designated into five groups (n = 5): Control group was not induced for BPH and not treated with tadalafil; dogs induced for BPH by testosterone enanthate and estradiol benzoate and treated with tadalafil (5 mg/day P.O.); dogs which received tadalafil (5 mg/day P.O.); dogs induced for BPH and treated with castration; and dogs induced for BPH. Oxidative stress factors (glutathione peroxidase [GPX], superoxide dismutase [SOD], catalase) and inflammatory proteins (haptoglobin, serum amyloid A [SAA], malondialdehyde [MDA]) were measured in the blood serum for four sequential weeks. Results Glutathione peroxidase and SOD serum levels declined in dogs in the BPH‐induced group compared to those in the control group. Those levels diminished in BPH‐induced castrated and tadalafil‐treated groups. The changes in the GPX and SOD serum concentrations were not significant between the BPH‐induced castrated group and BPH‐induced tadalafil‐treated group. Moreover, MDA concentration increased slightly in groups with BPH and groups which were castrated. Generally, however, there were no significant differences in the MDA serum concentrations between other groups. Haptoglobin and SAA concentrations increased in BPH‐castrated group. Also, the differences in haptoglobin and SAA were not significant between the groups. Conclusion Tadalafil could not control oxidative stress and inflammatory mediators which happened during BPH in dogs.
doi_str_mv 10.1111/jvp.12805
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2273231116</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2273231116</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3255-94af575e122c8155c6ba21671e9fef032497e3f7b256d62858403f0ba4443613</originalsourceid><addsrcrecordid>eNp1kctOGzEUhi3UCsJlwQsgL9vFgK8zzhKitlAhlQXqdnQyc5wYecZh7CTNro_Qd-ib8SQYhrKrZcmS_Z3PR-cn5JSzc57XxcNmdc6FYXqPTLgsdSGM0R_IhHHFiqoy8oAcxvjAGJOG831yILnizFRqQv7OltAvMFLX07REGn65FpLbII1pwBiphSaFIVLo28xYD10H-WJHV0NI6PpMBO_D1vWLV0GugtRhn2iw9Oru-un3H9e36wZb2oZFpFuXllmWd3L5LVu8sziMf8LipbAB7zOeoAUP1vlj8tGCj3jydh6R-69f7mfXxe2Pbzezy9uikULrYqrA6kojF6IxXOumnIPgZcVxatEyKdS0QmmrudBlWwqjjWLSsjkopWTJ5RH5NGpzT49rjKnuXGzQe-gxrGMtRCWFzPMuM_p5RJshxDigrVeD62DY1ZzVL5HUOZL6NZLMnr1p1_MO23fyXwYZuBiBrfO4-7-p_v7zblQ-A42Qmjs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2273231116</pqid></control><display><type>article</type><title>Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH‐induced dogs with an anti‐proliferative agent called tadalafil</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Dearakhshandeh, Nooshin ; Mogheiseh, Asghar ; Nazifi, Saeed ; Ahrari Khafi, Mohammad Saeed ; Abbaszadeh Hasiri, Mohammad ; Golchin‐Rad, Kamran</creator><creatorcontrib>Dearakhshandeh, Nooshin ; Mogheiseh, Asghar ; Nazifi, Saeed ; Ahrari Khafi, Mohammad Saeed ; Abbaszadeh Hasiri, Mohammad ; Golchin‐Rad, Kamran</creatorcontrib><description>Background Finding a medical treatment which can combat cell proliferation and relax smooth muscles in canine benign prostatic hyperplasia (BPH) appears to be imperative. Aims This study aimed to evaluate the oxidative stress and inflammatory proteins following the treatment of dogs induced for BPH with an anti‐proliferative agent called tadalafil. Materials and Methods Twenty‐five adult intact male dogs were randomly designated into five groups (n = 5): Control group was not induced for BPH and not treated with tadalafil; dogs induced for BPH by testosterone enanthate and estradiol benzoate and treated with tadalafil (5 mg/day P.O.); dogs which received tadalafil (5 mg/day P.O.); dogs induced for BPH and treated with castration; and dogs induced for BPH. Oxidative stress factors (glutathione peroxidase [GPX], superoxide dismutase [SOD], catalase) and inflammatory proteins (haptoglobin, serum amyloid A [SAA], malondialdehyde [MDA]) were measured in the blood serum for four sequential weeks. Results Glutathione peroxidase and SOD serum levels declined in dogs in the BPH‐induced group compared to those in the control group. Those levels diminished in BPH‐induced castrated and tadalafil‐treated groups. The changes in the GPX and SOD serum concentrations were not significant between the BPH‐induced castrated group and BPH‐induced tadalafil‐treated group. Moreover, MDA concentration increased slightly in groups with BPH and groups which were castrated. Generally, however, there were no significant differences in the MDA serum concentrations between other groups. Haptoglobin and SAA concentrations increased in BPH‐castrated group. Also, the differences in haptoglobin and SAA were not significant between the groups. Conclusion Tadalafil could not control oxidative stress and inflammatory mediators which happened during BPH in dogs.</description><identifier>ISSN: 0140-7783</identifier><identifier>EISSN: 1365-2885</identifier><identifier>DOI: 10.1111/jvp.12805</identifier><identifier>PMID: 31410874</identifier><language>eng</language><publisher>England</publisher><subject><![CDATA[Androgens - administration & dosage ; Androgens - toxicity ; Animals ; benign prostatic hyperplasia ; castration ; Contraceptive Agents, Hormonal - administration & dosage ; Contraceptive Agents, Hormonal - toxicity ; Dog Diseases - chemically induced ; Dog Diseases - drug therapy ; Dogs ; Estradiol - administration & dosage ; Estradiol - analogs & derivatives ; Estradiol - toxicity ; Gene Expression Regulation - drug effects ; inflammation ; Inflammation - drug therapy ; Inflammation - metabolism ; Male ; oxidative stress ; Oxidative Stress - drug effects ; Phosphodiesterase 5 Inhibitors - therapeutic use ; Prostatic Hyperplasia - veterinary ; tadalafil ; Tadalafil - therapeutic use ; Testosterone - administration & dosage ; Testosterone - analogs & derivatives ; Testosterone - toxicity]]></subject><ispartof>Journal of veterinary pharmacology and therapeutics, 2019-11, Vol.42 (6), p.665-672</ispartof><rights>2019 John Wiley &amp; Sons Ltd</rights><rights>2019 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3255-94af575e122c8155c6ba21671e9fef032497e3f7b256d62858403f0ba4443613</citedby><cites>FETCH-LOGICAL-c3255-94af575e122c8155c6ba21671e9fef032497e3f7b256d62858403f0ba4443613</cites><orcidid>0000-0002-3136-2288</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjvp.12805$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjvp.12805$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31410874$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dearakhshandeh, Nooshin</creatorcontrib><creatorcontrib>Mogheiseh, Asghar</creatorcontrib><creatorcontrib>Nazifi, Saeed</creatorcontrib><creatorcontrib>Ahrari Khafi, Mohammad Saeed</creatorcontrib><creatorcontrib>Abbaszadeh Hasiri, Mohammad</creatorcontrib><creatorcontrib>Golchin‐Rad, Kamran</creatorcontrib><title>Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH‐induced dogs with an anti‐proliferative agent called tadalafil</title><title>Journal of veterinary pharmacology and therapeutics</title><addtitle>J Vet Pharmacol Ther</addtitle><description>Background Finding a medical treatment which can combat cell proliferation and relax smooth muscles in canine benign prostatic hyperplasia (BPH) appears to be imperative. Aims This study aimed to evaluate the oxidative stress and inflammatory proteins following the treatment of dogs induced for BPH with an anti‐proliferative agent called tadalafil. Materials and Methods Twenty‐five adult intact male dogs were randomly designated into five groups (n = 5): Control group was not induced for BPH and not treated with tadalafil; dogs induced for BPH by testosterone enanthate and estradiol benzoate and treated with tadalafil (5 mg/day P.O.); dogs which received tadalafil (5 mg/day P.O.); dogs induced for BPH and treated with castration; and dogs induced for BPH. Oxidative stress factors (glutathione peroxidase [GPX], superoxide dismutase [SOD], catalase) and inflammatory proteins (haptoglobin, serum amyloid A [SAA], malondialdehyde [MDA]) were measured in the blood serum for four sequential weeks. Results Glutathione peroxidase and SOD serum levels declined in dogs in the BPH‐induced group compared to those in the control group. Those levels diminished in BPH‐induced castrated and tadalafil‐treated groups. The changes in the GPX and SOD serum concentrations were not significant between the BPH‐induced castrated group and BPH‐induced tadalafil‐treated group. Moreover, MDA concentration increased slightly in groups with BPH and groups which were castrated. Generally, however, there were no significant differences in the MDA serum concentrations between other groups. Haptoglobin and SAA concentrations increased in BPH‐castrated group. Also, the differences in haptoglobin and SAA were not significant between the groups. Conclusion Tadalafil could not control oxidative stress and inflammatory mediators which happened during BPH in dogs.</description><subject>Androgens - administration &amp; dosage</subject><subject>Androgens - toxicity</subject><subject>Animals</subject><subject>benign prostatic hyperplasia</subject><subject>castration</subject><subject>Contraceptive Agents, Hormonal - administration &amp; dosage</subject><subject>Contraceptive Agents, Hormonal - toxicity</subject><subject>Dog Diseases - chemically induced</subject><subject>Dog Diseases - drug therapy</subject><subject>Dogs</subject><subject>Estradiol - administration &amp; dosage</subject><subject>Estradiol - analogs &amp; derivatives</subject><subject>Estradiol - toxicity</subject><subject>Gene Expression Regulation - drug effects</subject><subject>inflammation</subject><subject>Inflammation - drug therapy</subject><subject>Inflammation - metabolism</subject><subject>Male</subject><subject>oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Phosphodiesterase 5 Inhibitors - therapeutic use</subject><subject>Prostatic Hyperplasia - veterinary</subject><subject>tadalafil</subject><subject>Tadalafil - therapeutic use</subject><subject>Testosterone - administration &amp; dosage</subject><subject>Testosterone - analogs &amp; derivatives</subject><subject>Testosterone - toxicity</subject><issn>0140-7783</issn><issn>1365-2885</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctOGzEUhi3UCsJlwQsgL9vFgK8zzhKitlAhlQXqdnQyc5wYecZh7CTNro_Qd-ib8SQYhrKrZcmS_Z3PR-cn5JSzc57XxcNmdc6FYXqPTLgsdSGM0R_IhHHFiqoy8oAcxvjAGJOG831yILnizFRqQv7OltAvMFLX07REGn65FpLbII1pwBiphSaFIVLo28xYD10H-WJHV0NI6PpMBO_D1vWLV0GugtRhn2iw9Oru-un3H9e36wZb2oZFpFuXllmWd3L5LVu8sziMf8LipbAB7zOeoAUP1vlj8tGCj3jydh6R-69f7mfXxe2Pbzezy9uikULrYqrA6kojF6IxXOumnIPgZcVxatEyKdS0QmmrudBlWwqjjWLSsjkopWTJ5RH5NGpzT49rjKnuXGzQe-gxrGMtRCWFzPMuM_p5RJshxDigrVeD62DY1ZzVL5HUOZL6NZLMnr1p1_MO23fyXwYZuBiBrfO4-7-p_v7zblQ-A42Qmjs</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>Dearakhshandeh, Nooshin</creator><creator>Mogheiseh, Asghar</creator><creator>Nazifi, Saeed</creator><creator>Ahrari Khafi, Mohammad Saeed</creator><creator>Abbaszadeh Hasiri, Mohammad</creator><creator>Golchin‐Rad, Kamran</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3136-2288</orcidid></search><sort><creationdate>201911</creationdate><title>Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH‐induced dogs with an anti‐proliferative agent called tadalafil</title><author>Dearakhshandeh, Nooshin ; Mogheiseh, Asghar ; Nazifi, Saeed ; Ahrari Khafi, Mohammad Saeed ; Abbaszadeh Hasiri, Mohammad ; Golchin‐Rad, Kamran</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3255-94af575e122c8155c6ba21671e9fef032497e3f7b256d62858403f0ba4443613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Androgens - administration &amp; dosage</topic><topic>Androgens - toxicity</topic><topic>Animals</topic><topic>benign prostatic hyperplasia</topic><topic>castration</topic><topic>Contraceptive Agents, Hormonal - administration &amp; dosage</topic><topic>Contraceptive Agents, Hormonal - toxicity</topic><topic>Dog Diseases - chemically induced</topic><topic>Dog Diseases - drug therapy</topic><topic>Dogs</topic><topic>Estradiol - administration &amp; dosage</topic><topic>Estradiol - analogs &amp; derivatives</topic><topic>Estradiol - toxicity</topic><topic>Gene Expression Regulation - drug effects</topic><topic>inflammation</topic><topic>Inflammation - drug therapy</topic><topic>Inflammation - metabolism</topic><topic>Male</topic><topic>oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Phosphodiesterase 5 Inhibitors - therapeutic use</topic><topic>Prostatic Hyperplasia - veterinary</topic><topic>tadalafil</topic><topic>Tadalafil - therapeutic use</topic><topic>Testosterone - administration &amp; dosage</topic><topic>Testosterone - analogs &amp; derivatives</topic><topic>Testosterone - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dearakhshandeh, Nooshin</creatorcontrib><creatorcontrib>Mogheiseh, Asghar</creatorcontrib><creatorcontrib>Nazifi, Saeed</creatorcontrib><creatorcontrib>Ahrari Khafi, Mohammad Saeed</creatorcontrib><creatorcontrib>Abbaszadeh Hasiri, Mohammad</creatorcontrib><creatorcontrib>Golchin‐Rad, Kamran</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of veterinary pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dearakhshandeh, Nooshin</au><au>Mogheiseh, Asghar</au><au>Nazifi, Saeed</au><au>Ahrari Khafi, Mohammad Saeed</au><au>Abbaszadeh Hasiri, Mohammad</au><au>Golchin‐Rad, Kamran</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH‐induced dogs with an anti‐proliferative agent called tadalafil</atitle><jtitle>Journal of veterinary pharmacology and therapeutics</jtitle><addtitle>J Vet Pharmacol Ther</addtitle><date>2019-11</date><risdate>2019</risdate><volume>42</volume><issue>6</issue><spage>665</spage><epage>672</epage><pages>665-672</pages><issn>0140-7783</issn><eissn>1365-2885</eissn><abstract>Background Finding a medical treatment which can combat cell proliferation and relax smooth muscles in canine benign prostatic hyperplasia (BPH) appears to be imperative. Aims This study aimed to evaluate the oxidative stress and inflammatory proteins following the treatment of dogs induced for BPH with an anti‐proliferative agent called tadalafil. Materials and Methods Twenty‐five adult intact male dogs were randomly designated into five groups (n = 5): Control group was not induced for BPH and not treated with tadalafil; dogs induced for BPH by testosterone enanthate and estradiol benzoate and treated with tadalafil (5 mg/day P.O.); dogs which received tadalafil (5 mg/day P.O.); dogs induced for BPH and treated with castration; and dogs induced for BPH. Oxidative stress factors (glutathione peroxidase [GPX], superoxide dismutase [SOD], catalase) and inflammatory proteins (haptoglobin, serum amyloid A [SAA], malondialdehyde [MDA]) were measured in the blood serum for four sequential weeks. Results Glutathione peroxidase and SOD serum levels declined in dogs in the BPH‐induced group compared to those in the control group. Those levels diminished in BPH‐induced castrated and tadalafil‐treated groups. The changes in the GPX and SOD serum concentrations were not significant between the BPH‐induced castrated group and BPH‐induced tadalafil‐treated group. Moreover, MDA concentration increased slightly in groups with BPH and groups which were castrated. Generally, however, there were no significant differences in the MDA serum concentrations between other groups. Haptoglobin and SAA concentrations increased in BPH‐castrated group. Also, the differences in haptoglobin and SAA were not significant between the groups. Conclusion Tadalafil could not control oxidative stress and inflammatory mediators which happened during BPH in dogs.</abstract><cop>England</cop><pmid>31410874</pmid><doi>10.1111/jvp.12805</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-3136-2288</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0140-7783
ispartof Journal of veterinary pharmacology and therapeutics, 2019-11, Vol.42 (6), p.665-672
issn 0140-7783
1365-2885
language eng
recordid cdi_proquest_miscellaneous_2273231116
source MEDLINE; Wiley Online Library All Journals
subjects Androgens - administration & dosage
Androgens - toxicity
Animals
benign prostatic hyperplasia
castration
Contraceptive Agents, Hormonal - administration & dosage
Contraceptive Agents, Hormonal - toxicity
Dog Diseases - chemically induced
Dog Diseases - drug therapy
Dogs
Estradiol - administration & dosage
Estradiol - analogs & derivatives
Estradiol - toxicity
Gene Expression Regulation - drug effects
inflammation
Inflammation - drug therapy
Inflammation - metabolism
Male
oxidative stress
Oxidative Stress - drug effects
Phosphodiesterase 5 Inhibitors - therapeutic use
Prostatic Hyperplasia - veterinary
tadalafil
Tadalafil - therapeutic use
Testosterone - administration & dosage
Testosterone - analogs & derivatives
Testosterone - toxicity
title Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH‐induced dogs with an anti‐proliferative agent called tadalafil
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T08%3A19%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20the%20oxidative%20stress%20factors%20and%20inflammatory%20proteins%20following%20the%20treatment%20of%20BPH%E2%80%90induced%20dogs%20with%20an%20anti%E2%80%90proliferative%20agent%20called%20tadalafil&rft.jtitle=Journal%20of%20veterinary%20pharmacology%20and%20therapeutics&rft.au=Dearakhshandeh,%20Nooshin&rft.date=2019-11&rft.volume=42&rft.issue=6&rft.spage=665&rft.epage=672&rft.pages=665-672&rft.issn=0140-7783&rft.eissn=1365-2885&rft_id=info:doi/10.1111/jvp.12805&rft_dat=%3Cproquest_cross%3E2273231116%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2273231116&rft_id=info:pmid/31410874&rfr_iscdi=true